KLOW-80
KLOW-80 is a synthetic peptide studied for its wound-healing and anti-inflammatory properties. It is a relatively newer research compound with a growing body of preclinical data suggesting utility in tissue repair and inflammatory conditions.
Quick facts
- Half-life
- ~2–4 hours
- Administration
- Subcutaneous injection / Topical
- Primary use
- Wound healing, anti-inflammatory, tissue repair
How it works
KLOW-80 is believed to modulate inflammatory cytokine pathways and promote fibroblast activity, supporting the formation of new connective tissue at injury sites. Its precise receptor targets are still being characterised in ongoing research.
Reported benefits
- Accelerated wound closure and tissue regeneration
- Reduction in localised inflammatory markers
- Potential synergy with BPC-157 in healing protocols
- Topical application studied for skin repair
Typical dosing protocol
Dosing
Research protocols vary; typically 100–300 mcg subcutaneously once daily near the target site
Cycle length
4–8 weeks
Dosing information is for educational reference only. Individual needs vary. Always consult a healthcare professional.
Safety & considerations
Limited human clinical data available. Research is primarily preclinical. Not approved for human use in the UK. Consult a healthcare professional before use.
Important: All content is for informational purposes only. Not medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.